APC 2024 Agenda
DOWNLOAD PROGRAM GUIDE HEREThursday April 4, 2024 |
||||
| Updated 2/26/2024 *Speakers and titles are subject to change | ||||
| Session | Speaker | Company | Time | |
| Registration and Coffee | 8:00AM-9:00AM | |||
| Conference Opening | Pedro Garcia Barrantes | Vertex | 9:00AM-9:05AM | |
| Speaker Introduction |
|
9:05AM-9:10AM | ||
|
MTA-cooperative PRMT5 Inhibitors For the Treatment of MTAP-deleted Cancers |
Kevin Cottrell | Tango Therapeutics | 9:10AM-9:40AM | |
| Speaker Introduction | Eamonn Comer | Kymera Therapeutics | 9:40AM-9:45AM | |
| Discovery of Potent, Orally Bioavailable IRAK4 Degraders for the Treatment of Oncology and Immuno-Inflammatory Diseases | Matt Weiss | Kymera Therapeutics | 9:45AM-10:15AM | |
| Speaker Introduction | Kenneth Boy | BMS | 10:15AM-10:20AM | |
| Sustainability-Driven Science: How Process Chemistry at Sanofi Integrates Eco-Design with Process Development | Eileen Hoang | Sanofi | 10:20AM-10:50AM | |
| AM Break | 10:50AM-11:10AM | |||
| Speaker Introduction | Andy Tsai | Treeline Bio | 11:10AM-11:15AM | |
| Discovery and Characterization of a First-in-Class Selective IKZF2 Glue Degrader for Immuno-Oncology Applications | Michael Visser | Novartis |
11:15AM-11:45AM |
|
| Plenary Speaker Introduction | Catherine Lebrun | Ananke Therapeutics | 11:45AM-11:50AM | |
|
Plenary Lecture Next-Generation Covalent Drug Discovery – Targeting Residues Beyond Cysteine |
Lyn Jones | Dana-Farber Cancer Institute | 11:50AM-12:35PM | |
| Lunch | 12:35PM-1:50PM | |||
| Speaker Introduction | David Ebner | Pfizer | 1:50PM-1:55PM | |
| Vendor Talk - Exploiting High-Energy Hydration Sites for the Discovery of Potent Peptide Aldehyde Inhibitors of the SARS-CoV-2 Main Protease with Cellular Antiviral Activity | Abba Leffler |  |
1:55PM-2:20PM | |
| Small Molecule GLP-1 Receptor Agonists Suitable for Once-daily Oral Administration | David Griffith | Pfizer | 2:20PM-2:50PM | |
| Speaker Introduction | Benoit Moreau | Remix Therapeutics | 2:50PM-2:55PM | |
| Rational Discovery and Design of Molecular Glue Degraders | Bernhard Fasching | Monte Rosa Therapeutics | 2:55PM-3:25PM | |
| PM Break | 3:25PM-3:40PM | |||
| Speaker Introduction | Andy Tsai | Treeline Bio | 3:40PM-3:45PM | |
| Identification of a Novel Linker Enabling Bioconjugation of a Cyclic Dinucleotide for the STING Antibody Drug Conjugate TAK-500 | Hong Myung Lee | Takeda | 3:45PM-4:15PM | |
| Plenary Speaker Introduction | Rebecca Casaubon | Exscientia | 4:15PM-4:20PM | |
|
Plenary Lecture Chemical Synthesis of Complex Molecules for Translational Science |
John A. Porco, Jr. | Boston University | 4:20PM-5:05PM | |
| Closing Remarks | David Ebner | Pfizer | 5:05PM - 5:10PM | |
| Reception | 5:10PM-6:10PM | |||